Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The primary hypothesis of this study is that 18F‐Fluciclovine PET/MRI imaging at two years following FCA will improve sensitivity for detection of in field recurrence of significant prostate cancer defined as any Gleason pattern 4 disease. The secondary hypothesis of this study is that 18F‐Fluciclovine PET/MRI imaging at two years following FCA will improve sensitivity for detection of out of field recurrence of significant prostate cancer .
Epistemonikos ID: 1589b3d3f58c2bcbcc3e2bf9ee11bc29fb3ecf20
First added on: May 22, 2024